Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 52, 5744-5751, October 15, 1992]
© 1992 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tuo, X.-H.
Right arrow Articles by Kannagi, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tuo, X.-H.
Right arrow Articles by Kannagi, R.

Stage-specific Expression of Cancer-associated Type 1 and Type 2 Chain Polylactosamine Antigens in the Developing Pancreas of Human Embryos1

Xiao-Hui Tuo, Shigeyuki Itai, Junko Nishikata, Tohru Mori, Osamu Tanaka and Reiji Kannagi2

Department of Laboratory Medicine, Kyoto University, School of Medicine, Kyoto [X-H. T., S. I., J. N., T. M.]; Department of Anatomy, Shimane Medical University, Izumo [O. T.]; and Laboratory of Experimental Pathology, Research Institute, Aichi Cancer Center, Nagoya [R. K.], Japan

Expression of type 1 and type 2 chain carbohydrate antigens during the course of morphogenesis of human embryonic pancreas was investigated using specific monoclonal antibodies and compared with the carbohydrate antigen profiles of human pancreatic cancers. The type 2 chain antigens, such as stage-specific embryonic antigen 1 (Lex) and I-antigens, appeared much earlier than the type 1 chain antigens; the epithelial cells of primitive foregut were Lex+I-antigen- in the embryos at Carnegie stages 16–23, while the pancreatic primordial cells, which had differentiated from the Lex+ gut epithelial cells, were Lex--I-antigen+ at Carnegie stages 22–23. The type 1 chain antigens, such as Lea, Leb, Lec, and their sialylated derivatives, were not expressed in any cells at these stages and appeared much later in the pancreas of the 10–12-week embryos, when the primitive pancreatic ductal cells in the primordia exhibited an extensive budding of the daughter cells. At this stage, Lea appeared and was expressed strongly in the epithelial cells of primitive pancreatic ducts as well as in the daughter cells that were destined to differentiate into future centroacinar cells; Leb was localized in the daughter cells which were to become future acinar cells; and Lec was specifically expressed in the daughter cells which were to form future Langerhans islets. With regard to the sialylated derivatives of Lea, expression of the 2–3 sialyl Lea antigen was limited to the epithelial cells of the primitive pancreatic ducts, while the 2–6 sialyl Lea antigen was strongly expressed in the future centroacinar cells, which had differentiated from the corresponding daughter cells. Among these antigens, the Lea and 2–3 sialyl Lea antigens showed the highest incidence in human pancreatic cancer tissues. These results indicate that the expression of these carbohydrate antigens in embryonic pancreas is differentiation dependent and cell lineage specific and that most human pancreatic cancer cells mimic the carbohydrate antigen profile of the epithelial cells of the primitive pancreatic ducts in human embryos.

1 Supported in part by grants-in-aid for Scientific Research from the Ministry of Education, Science and Culture, Japan (03557114 and 03258218) (R. K.).

2 To whom requests for reprints should be addressed, at Laboratory of Experimental Pathology, Research Institute, Aichi Cancer Center, 1-1 Kanokoden, Chikusaku, Nagoya, 464, Japan.

Received 5/ 4/92. Accepted 8/ 7/92.




This article has been cited by other articles:


Home page
Ann. N. Y. Acad. Sci.Home page
K. FURUKAWA, K. HAMAMURA, W. AIXINJUELUO, and K. FURUKAWA
Biosignals Modulated by Tumor-Associated Carbohydrate Antigens: Novel Targets for Cancer Therapy
Ann. N.Y. Acad. Sci., November 1, 2006; 1086(1): 185 - 198.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
A. Cailleau-Thomas, P. Coullin, J.-J. Candelier, L. Balanzino, B. Mennesson, R. Oriol, and R. Mollicone
FUT4 and FUT9 genes are expressed early in human embryogenesis
Glycobiology, August 1, 2000; 10(8): 789 - 802.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
M. Hariri, G. Millane, M.-P. Guimond, G. Guay, J. W. Dennis, and I. R. Nabi
Biogenesis of Multilamellar Bodies via Autophagy
Mol. Biol. Cell, January 1, 2000; 11(1): 255 - 268.
[Abstract] [Full Text]


Home page
Ann. N. Y. Acad. Sci.Home page
M. A. HOLLINGSWORTH
Proteins Expressed by Pancreatic Duct Cellsand Their Relatives
Ann. N.Y. Acad. Sci., June 30, 1999; 880(1): 38 - 49.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Hennet, A. Dinter, P. Kuhnert, T. S. Mattu, P. M. Rudd, and E. G. Berger
Genomic Cloning and Expression of Three Murine UDP-galactose: beta -N-Acetylglucosamine beta 1,3-Galactosyltransferase Genes
J. Biol. Chem., January 2, 1998; 273(1): 58 - 65.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Oulmouden, A. Wierinckx, J.-M. Petit, M. Costache, M. M. Palcic, R. Mollicone, R. Oriol, and R. Julien
Molecular Cloning and Expression of a Bovine alpha (1,3)-Fucosyltransferase Gene Homologous to a Putative Ancestor Gene of the Human FUT3-FUT5-FUT6 Cluster
J. Biol. Chem., March 28, 1997; 272(13): 8764 - 8773.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. C.M.B.-V. d. Linden, R. Mollicone, R. Oriol, G. Larson, D. H.V. d. Eijnden, and W. Van Dijk
A Missense Mutation in the FUT6 Gene Results in Total Absence of alpha 3-Fucosylation of Human alpha 1-Acid Glycoprotein
J. Biol. Chem., June 14, 1996; 271(24): 14492 - 14495.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1992 by the American Association for Cancer Research.